HST Global FCF per Share
The Free Cash Flow per Share of HST Global (HSTC) as of Oct 31, 2026 is -0.01 USD.
Get this data via API
Financial Data API
FCF per Share
-0.01USD
YoY
94.40%
Last updated:
Free Cash Flow per Share of HST Global is 2025 -0.01 USD. Free Cash Flow per Share of HST Global was 2024 -0.00 USD. It decreases by 94.40% lower compared to the previous year.
The HST Global FCF per Share history
3 Years
10 Years
25 Years
Max
FCF per Share
Date
FCF per Share
Jan 1, 2017
-0.01 USD
Jan 1, 2018
-0.01 USD
Jan 1, 2019
-0.02 USD
Jan 1, 2020
-0.01 USD
Jan 1, 2021
-0.01 USD
Jan 1, 2022
-0.00 USD
Jan 1, 2023
-0.00 USD
Jan 1, 2025
-0.01 USD
| YEAR | FCF per Share | YoY |
|---|---|---|
| -0.01USD | +94.40% | |
| -0.00USD | -0.61% | |
| -0.00USD | -29.50% | |
| -0.01USD | +10.62% | |
| -0.01USD | -76.25% | |
| -0.02USD | +141.50% | |
| -0.01USD | -32.15% | |
| -0.01USD | +47.51% | |
| -0.01USD | +24.82% | |
| -0.01USD | -28.44% | |
| -0.01USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
HST Global Stock analysis
What does HST Global do? HST Global Inc is a company that focuses on the development and marketing of technology solutions for the healthcare sector. The company was founded in 2004 and is headquartered in Hampton, Virginia, USA. HST Global Inc has become a significant player in the global medical technology market in recent years and offers a wide range of products and services for medical facilities and healthcare professionals.
The history of HST Global Inc is closely linked to the history of advancements in medical technology. The company has always focused on researching and developing innovative technologies that enable better and faster diagnosis, treatment, and prevention of diseases. The company has an impressive list of patents and intellectual property rights that allow it to develop innovative solutions in collaboration with its customers.
HST Global Inc offers a wide range of products and services that are divided into four main areas: biotechnology, medical devices, information and communication technology, and healthcare services. The biotechnology division includes a variety of technology solutions that enable the company and its customers to develop new drugs and therapies. The medical devices division encompasses a wide range of devices and instruments used in hospitals and clinics to enable precise diagnosis and treatment of diseases. The information and communication technology division focuses on the development of software and technology solutions that enable effective and secure transmission of medical data and information. The healthcare services division offers a wide range of services tailored to the specific needs of patient groups.
HST Global Inc's products and services also include a variety of solutions focused on the diagnosis and treatment of cancer and other life-threatening diseases. These products and services include technologies for cancer cell detection, development of personalized cancer treatments, and monitoring the effectiveness of cancer treatments.
HST Global Inc has also specialized in developing solutions to improve the health of people in developing countries. The company has developed programs aimed at improving access to medical care and healthcare services in rural areas and developing countries. HST Global Inc relies on a combination of innovative technology and local knowledge to create solutions tailored to the needs of the local population.
The business model of HST Global Inc is based on close collaboration with medical facilities and professionals. By developing innovative solutions in collaboration with its customers, the company can provide added value to its customers and meet their needs. The company also has a dedicated research and development unit that continuously develops new products and technologies to meet the ever-changing demands of the market.
Overall, HST Global Inc has experienced an impressive success story in the medical technology market in recent years. The company has a strong presence in the global market and offers a wide range of products and services tailored to the needs of medical facilities and professionals. The company is also committed to expanding its expertise in biotechnology and medical technology to offer an even broader range of solutions to its customers. HST Global is one of the most popular companies on Eulerpool.
Frequently Asked Questions about HST Global stock
Free Cash Flow per Share of HST Global is -0.01 USD in 2025.
On Eulerpool you can find the complete historical development of Free Cash Flow per Share HST Global since 2006 – with annual values, charts, and detailed analysis.
FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Cash Flow — HST Global
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — HST Global
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth